RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
<p><em>The article presents literature review on the role of B-lymphocytes in pathogenesis of rheumatologic diseases and on the administration of chimeric anti-CD20 monoclonal antibodies — rituximab — for treatment of systemic lupus erythematosus, systemic vasculitis, juvenile dermatomyo...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2010-01-01
|
| Series: | Вопросы современной педиатрии |
| Online Access: | http://vsp.spr-journal.ru:80/jour/article/view/891 |
| _version_ | 1797710977499660288 |
|---|---|
| author | E.I. Alexeeva R.V. Denisova S.I. Valieva T.M. Bzarova A.O. Lisitsyn |
| author_facet | E.I. Alexeeva R.V. Denisova S.I. Valieva T.M. Bzarova A.O. Lisitsyn |
| author_sort | E.I. Alexeeva |
| collection | DOAJ |
| description | <p><em>The article presents literature review on the role of B-lymphocytes in pathogenesis of rheumatologic diseases and on the administration of chimeric anti-CD20 monoclonal antibodies — rituximab — for treatment of systemic lupus erythematosus, systemic vasculitis, juvenile dermatomyositis, and juvenile arthritis in children. Results of studies showed that rituximab has good tolerability, efficacy and safety in children’s rheumatologic practice.</em><strong><em></em></strong></p><p><strong><em>Key words: children, B-lymphocytes, rituximab, treatment, depletion.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em>Voprosy sovremennoi pediatrii — </em></em>Current Pediatrics. – 2010;9(3):<em>54-62</em>)</em></span></p> |
| first_indexed | 2024-03-12T07:00:15Z |
| format | Article |
| id | doaj.art-97433776ccd747979c6f2d6c2ce61a92 |
| institution | Directory Open Access Journal |
| issn | 1682-5527 1682-5535 |
| language | English |
| last_indexed | 2024-03-12T07:00:15Z |
| publishDate | 2010-01-01 |
| publisher | "Paediatrician" Publishers LLC |
| record_format | Article |
| series | Вопросы современной педиатрии |
| spelling | doaj.art-97433776ccd747979c6f2d6c2ce61a922023-09-02T23:45:59Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352010-01-01935462892RITUXIMAB IN PEDIATRIC RHEUMATOLOGYE.I. Alexeeva0R.V. Denisova1S.I. Valieva2T.M. Bzarova3A.O. Lisitsyn4Scientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow<p><em>The article presents literature review on the role of B-lymphocytes in pathogenesis of rheumatologic diseases and on the administration of chimeric anti-CD20 monoclonal antibodies — rituximab — for treatment of systemic lupus erythematosus, systemic vasculitis, juvenile dermatomyositis, and juvenile arthritis in children. Results of studies showed that rituximab has good tolerability, efficacy and safety in children’s rheumatologic practice.</em><strong><em></em></strong></p><p><strong><em>Key words: children, B-lymphocytes, rituximab, treatment, depletion.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em>Voprosy sovremennoi pediatrii — </em></em>Current Pediatrics. – 2010;9(3):<em>54-62</em>)</em></span></p>http://vsp.spr-journal.ru:80/jour/article/view/891 |
| spellingShingle | E.I. Alexeeva R.V. Denisova S.I. Valieva T.M. Bzarova A.O. Lisitsyn RITUXIMAB IN PEDIATRIC RHEUMATOLOGY Вопросы современной педиатрии |
| title | RITUXIMAB IN PEDIATRIC RHEUMATOLOGY |
| title_full | RITUXIMAB IN PEDIATRIC RHEUMATOLOGY |
| title_fullStr | RITUXIMAB IN PEDIATRIC RHEUMATOLOGY |
| title_full_unstemmed | RITUXIMAB IN PEDIATRIC RHEUMATOLOGY |
| title_short | RITUXIMAB IN PEDIATRIC RHEUMATOLOGY |
| title_sort | rituximab in pediatric rheumatology |
| url | http://vsp.spr-journal.ru:80/jour/article/view/891 |
| work_keys_str_mv | AT eialexeeva rituximabinpediatricrheumatology AT rvdenisova rituximabinpediatricrheumatology AT sivalieva rituximabinpediatricrheumatology AT tmbzarova rituximabinpediatricrheumatology AT aolisitsyn rituximabinpediatricrheumatology |